Treatment Registry
TR-1038 ActiveRecorded October 2026

Compounded semaglutide

Sold by Goldspan Health · Injection · device not recorded · every compounded semaglutide record

The program identifies an injection, but the delivery device has not been established.

Price

TermPublished rateCharged today
B12 option; advertised starting charge every 28 days, payment unverified

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription requires clinician approval. The page advertises a starting amount; selected dose and final invoice are not established. Required later lab work is separately priced at an unpublished amount.

Advertised

“Monthly Billed every 28 days $229 /mo”

$229Published figureCharged todayNot verified
glycine option; advertised starting charge every 28 days, payment unverified

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription requires clinician approval. The page advertises a starting amount; selected dose and final invoice are not established. Required later lab work is separately priced at an unpublished amount.

Advertised

“Monthly Billed every 28 days $229 /mo”

$229Published figureCharged todayNot verified
Price sources
Visit Goldspan Health

We earn nothing from this link. It opens Goldspan Health's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberBoth
CancellationThe product FAQ allows cancellation of the next order before it processes, or a delayed refill/pause. Goldspan's refund policy makes placed orders final except clinician prescription denial; lost/damaged deliveries must be reported within seven days. Linked Altro terms also restrict cancellation/refunds after ordering and provide no prorated subscription refund. Confirm the processing cutoff before ordering. https://www.altroapp.com/goldspan/rx/c4317c07-7170-41dc-a497-4327647fe850 https://goldspanhealth.com/refunds https://altrohealth.com/end-user-terms-of-service
MembershipNot disclosed
Consult feeIncluded in program price; itemized amount is not published. The product includes clinician evaluation and prescription when appropriate; do not add a second consultation charge. Required lab work after 60–90 days and annually has an unpublished separate cost. https://www.altroapp.com/goldspan/rx/c4317c07-7170-41dc-a497-4327647fe850

Recorded from goldspanhealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — Both B12 and glycine options were reviewed. Each is described as compounded and injectable with syringes/alcohol pads supplied, but the medication container is not explicitly identified. These are additive options within this ingredient/form record. https://goldspanhealth.com/category/weight-loss https://www.altroapp.com/goldspan/rx/c4317c07-7170-41dc-a497-4327647fe850
  2. 2. October 2026 — Although the headline uses /month, the actual plan bills every 28 days and renews every four weeks. The recorded amount must not be converted into a calendar-month price. The advertised starting amount does not establish the selected dose or final payment. https://www.altroapp.com/goldspan/rx/c4317c07-7170-41dc-a497-4327647fe850
  3. 3. October 2026 — The plan includes evaluation, medication when prescribed, injection supplies, two-day shipping and ongoing care-team access. A lab panel is required after 60–90 days and annually; its exact additional cost is unpublished. A questionnaire is reviewed by a clinician, with a video consultation when required by medical history or geography. No named dispensing pharmacy is established. https://www.altroapp.com/goldspan/rx/c4317c07-7170-41dc-a497-4327647fe850
  4. 4. October 2026 — The platform footer advertises availability in all 50 states and DC, while Goldspan's terms and the linked platform terms limit some therapies by state. An unconditional program-specific coverage roster is not established. https://goldspanhealth.com/terms https://altrohealth.com/end-user-terms-of-service https://www.altroapp.com/goldspan/rx/c4317c07-7170-41dc-a497-4327647fe850

4 further notes concern other Goldspan Health programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-1038
Medication category
compounded semaglutide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Goldspan Health — compounded semaglutide (TR-1038). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-1038

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.